NY/NJ Chapter: Accelerating Medical Product Development at FDA – Drivers, Initiatives and Actions

RAC Credits
Thursday, 21 March 2019 (5:30 PM) - Thursday, 21 March 2019 (8:00 PM)
1425 US Highway 206
Bedminster, NewJersey, USA, 07921-2653

Thursday, 21 March 2019
5:30-8:00 pm EDT
Mallinckrodt Pharmaceuticals
1425 U.S. Route 206
Bedminster, NJ 07921 

+1 908 238 6600

Advanced registration is now closed. Onsite registration will not be accepted.

Engage with others from your local regulatory community and hear an interactive presentation on significant actions in 2018 to accelerate and modernize medical product development. The speakers will also explore the Agency’s initiatives to promote competition and access, as well as noteworthy events and emerging trends impacting FDA in 2019.

The engagement activity, hosted by Mallinckrodt Pharmaceuticals, is brought to you by the RAPS New York/New Jersey chapter and is intended to promote professional development and networking opportunities in the local regulatory community. Light refreshments will be available to all attendees and RAC  holders may claim two RAC recertification credits.

Tab: Speakers/Faculty
Kimberly BelskyM.S. executive director, regulatory policy and intelligence, regulatory affairs
Kendra Martello, senior director, public policy, government affairs and public policy

Registration Information:
RAPS Members: $30
Nonmembers: $45

Registration Closes: 18 March 2019